Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05923463 · ClinicalTrials.gov registry record · NA
Precision Feedback to Improve Health Care Quality
A NA study of Anesthesia Care Quality, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 3,500
- Enrollment target
- 1
- Study location
NCT05923463: Active NA study of Anesthesia Care Quality, sponsored by University of Michigan.
NCT05923463 is a NA study of Anesthesia Care Quality that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 3,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05923463, a NA study of Anesthesia Care Quality, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This cluster-randomized trial will assess the effectiveness of a precision feedback service on anesthesia provider performance. The precision feedback service enhances a standard audit and feedback (A\&F) email with a brief message and visual display about high-value performance information. The control arm will receive a standard "one size fits most" A\&F email that is currently sent to anesthesia providers each month. Hypothesis: Providers receiving precision feedback will increase a) care quality for improvable measures and b) email engagement (click-through and dashboard login rates) when compared with providers receiving standard A\&F emails. The study investigators will assess unintended consequences in a mixed-methods process evaluation.
Primary Outcome
The primary outcome for the cluster-randomized controlled trial is the measure success rate (M) for operative cases of anesthesia care providers, where: M = sum of all operative case measurement successes / number of all operative case measurements The measures included in each provider's measure success rate will be all improvable process measures that meet the following inclusion criteria: 1. A provider's cases were included for the measure during both the 6-month pre-intervention period an
Conditions Studied
Interventions
- BEHAVIORAL precision-enhanced feedback email messages
- BEHAVIORAL standard feedback email messages
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2025-06 |
| Phase | NA |
What the registry record for NCT05923463 still lists
NCT05923463 is an interventional study that assigns participants to a tested intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher).
The record links to 1 condition, with Anesthesia Care Quality appearing as the primary indexed condition, and to 2 interventions - of which precision-enhanced feedback email messages is the first listed.
NCT05923463 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05923463 about?
NCT05923463 is a clinical study titled "Precision Feedback to Improve Health Care Quality". This cluster-randomized trial will assess the effectiveness of a precision feedback service on anesthesia provider performance. The precision feedback service enhances a standard audit and feedback (A\&F) email with a brief message and visual display about high-value performance information. The con...
What is the current status of trial NCT05923463?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,500 participants. The study started on 2024-05-06. Estimated completion is 2025-06.
What conditions does trial NCT05923463 study?
This clinical trial studies the following conditions: Anesthesia Care Quality.
What interventions are being tested in trial NCT05923463?
The interventions under investigation include: precision-enhanced feedback email messages (BEHAVIORAL), standard feedback email messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05923463?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05923463 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05923463's enrollment target sits among peer trials
3,500 36th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI